Early research (Phase 1)Study completedNCT05524545
What this trial is testing
Evorpacept (ALX148) With Enfortumab Vedotin for Subjects With Urothelial Carcinoma (ASPEN-07)
Who this might be right for
Bladder CancerUrothelial Carcinoma
ALX Oncology Inc. 36